Imatinib Unknown Status Phase 2 Trials for Cancers of the Head and Neck / Carcinoma, Adenoid Cystic Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00180921Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck